Global Neurology Devices Market

Neurology Devices Market Size, Share, Growth Analysis, By Product(Neurostimulation Devices, Neurosurgery Devices, Interventional Neurology Devices, Cerebrospinal Fluid Devices), By End User(Hospitals, Neurology Clinics, and Ambulatory Care Centers), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2500 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 65 | Figures: 75

Neurology Devices Market Insights

Global Neurology Devices Market size was valued at USD 14.58 Billion in 2022 and is poised to grow from USD 15.76 Billion in 2023 to USD 29.39 Billion by 2031, at a CAGR of 8.1% during the forecast period (2024-2031).

Neurology devices aim to diagnose, prevent and treat a wide range of neurological disorders such as parkinson’s disease, alzheimer’s disease epilepsy, traumatic brain injury, spinal cord injury, and epilepsy. The neurology device plays a vital role in enhancing patient outcomes and improving the quality of life for patients with neurological disorders. This device aims to provide healthcare professionals with advanced technologies and tools in order to diagnose and treat neurological disorders.  

These devices assist in monitoring disease progression, detect abnormalities, and facilitate therapeutic intervention. These devices also enable early diagnosis and treatment, and improve patient care with better clinical outcomes. 

The increasing prevalence of neurological disorder, and surge in need for early diagnosis propel the growth of the market. The rising incidence of stroke, and epilepsy, increase the demand for neurological devices. In addition, there is an increase in demand for effective diagnosis and treatment solutions, which enhance patient outcomes.  

Furthermore, the stringent regulatory requirement to obtain regulatory approvals, and high cost of neurological devices hinder the growth of the market. 

In addition, the advancement in technology and innovation in medical device company, propel the growth of the market. As medical professional and researcher, conduct continuous research on medical devices, which increase the demand for sophisticated devices that offer accurate diagnosis, and enhance patient outcomes. Thus, increase in research and development activities in the medical device sector, rise in funds for development of healthcare facilities , and initiative taken by the government for development of the medical device industry boost the market growth. 

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Neurology Devices Market size was valued at USD 14.58 Billion in 2022 and is poised to grow from USD 15.76 Billion in 2023 to USD 29.39 Billion by 2031, at a CAGR of 8.1% during the forecast period (2024-2031).

The global neurology devices market is characterized by intense competition among key players striving to gain a significant market share. The market is a mix of established multinational companies and smaller regional players focusing on niche segments. These companies are continuously engaged in research and development activities to introduce innovative products and maintain their competitive edge. To stay competitive, companies are investing heavily in research and development to introduce advanced technologies and enhance their product portfolios. They are focused on developing minimally invasive devices, integrating AI and machine learning algorithms, and exploring new applications of neurostimulation and neuroimaging technologies. Additionally, strategic collaborations, partnerships, and acquisitions are prevalent in the market to expand geographic reach, enhance product offerings, and gain a competitive advantage. 'Medtronic (US)', 'Abbott Laboratories (US)', 'Boston Scientific Corporation (US)', 'Koninklijke Philips N.V. (Netherlands)', 'Siemens Healthineers AG (Germany)', 'Stryker Corporation (US)', 'GE Healthcare (US)', 'Johnson & Johnson (US)', 'Zimmer Biomet Holdings, Inc. (US)', 'Nihon Kohden Corporation (Japan)', 'Hitachi, Ltd. (Japan)', 'Brainlab AG (Germany)', 'Elekta AB (Sweden)', 'LivaNova PLC (UK)', 'Nevro Corp. (US)', 'Natus Medical Incorporated (US)', 'Penumbra, Inc. (US)', 'Integra LifeSciences Holdings Corporation (US)', 'Terumo Corporation (Japan)', 'Neuropace, Inc. (US)'

The increasing prevalence of neurological disorders, such as Alzheimer's disease, Parkinson's disease, and epilepsy, continues to drive the demand for neurology devices. According to the World Health Organization (WHO), neurological disorders affect millions of people globally, necessitating advanced diagnostic and therapeutic solutions.

Shift towards Minimally Invasive Procedures: There is a notable trend towards minimally invasive procedures in the field of neurology. Minimally invasive techniques offer advantages such as reduced postoperative complications, shorter hospital stays, and quicker recovery times. This trend drives the demand for neurology devices that enable precise interventions with minimal tissue disruption.

North America holds the largest market share in the global neurology devices market, primarily due to the presence of well-established healthcare infrastructure, advanced technological advancements, and a high prevalence of neurological disorders. The region's dominance can be attributed to the significant investments in research and development, strong collaborations between industry players and academic institutions, and favorable reimbursement policies.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Neurology Devices Market

Report ID: SQMIG35A2500

$5,300
BUY NOW GET FREE SAMPLE